Randomized trial support for mild premenstrual symptom relief; structure/function only. Not for use in pregnancy or with hormone-altering medications without clinician guidance.
How it works
Sense — constituents show dopaminergic activity that may modulate prolactin secretion, a proposed mechanism for relief of common premenstrual symptoms
Regulate — by modulating dopamine (D2 receptor) activity at the pituitary, chasteberry indirectly influences the broader hypothalamic-pituitary-gonadal signaling axis rather than acting directly on ovarian or uterine tissue -- a centrally-acting rather than locally-acting mechanism
Exchange — active diterpenoid constituents are fat-soluble and their oral bioavailability is not fully characterized, so standardized extracts (dosed to a specific diterpenoid content) are used in the clinical trial literature rather than raw crushed berry
Adapt — traditional use favors consistent daily dosing over 2-3 menstrual cycles before assessing effect, consistent with a gradual hormonal-axis modulation rather than an acute symptom-relief mechanism
Form matters
The same nutrient can be made in very different forms — and a study done on one form does not automatically apply to another. Methylcobalamin is not cyanocobalamin; magnesium glycinate is not magnesium oxide; a whole-food extract is not the synthetic isolate that was studied. Two things decide whether what is in the bottle behaves like the research: the exact form, and independent lab verification (a Certificate of Analysis) that the form and dose on the label are truly what is inside. Without a COA, you are trusting a label, not the science.
Works well with
The science on Chasteberry (Vitex)
Powered by CellWell.lifeBalanced by design — we show supporting and contradicting findings. Search all studies